Pre-Diabetes Discovery Marks Step Towards Precision Medicine
Researchers from the University of Sydney’s Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes – a major predictor of metabolic syndrome, the collection of medical conditions that include abdominal obesity, high blood pressure and high blood sugar levels.
The finding, from a study undertaken in mice, could make earlier detection of pre-diabetes in humans much easier for doctors and allow for more personalised and effective treatments for patients in the future.
Researchers combined the high-tech mathematical approach of machine learning with omics technology that examines the various types of molecules that make up the cells of an organism to successfully identify specific molecules in mice. That information was used to classify the mice according to what kind of food they eat, their genetic origin and their whole-body insulin sensitivity.
Published in the Journal of Biological Chemistry, the research was conducted with the Garvan Institute of Medical Research, Duke University (USA) and the University of Melbourne.
Co-lead author Dr Jacqueline Stöckli, a research fellow with the University’s Charles Perkins Centre and School of Life and Environmental Sciences, said the study suggested there are likely multiple factors that contribute to pre-diabetes and this is why more traditional approaches have failed to identify similar highly predictive signatures or indicators of disease.
“Our study identified a three molecule signature that was able to diagnose insulin resistance or pre-diabetes, a condition that is often associated with diabetes, obesity and high blood pressure,” she said.
“But we know the story is much more complicated; strikingly, each of the three molecules on their own was considerably less predictive of pre-diabetes than when combined.
“The next step is to further exploit these technologies to uncover the full suite of pathways and factors that contribute to pre-diabetes – which will include genetic, environmental and possibly epigenetic influences – at a population level.”
The study represented a segue into precision medicine for humans, said senior author Professor David James, Leonard P. Ullmann Chair of Metabolic Systems Biology at the Charles Perkins Centre.
Precision medicine classifies individuals according to their susceptibility or response to a particular disease, and tailors healthcare treatments and practices accordingly.
“Once we can identify the molecules and other factors that contribute to pre-diabetes, we can customise treatments to suit patients’ specific make up and needs,” Professor James said.
“This study demonstrates the power of combining technologies to solve some of the world’s biggest problems,” he added.
“The burden of the ‘lifestyle diseases’ the Charles Perkins Centre is dedicated to easing – which include obesity, diabetes and cardiovascular disease – stubbornly remain at high levels globally; we need to innovate in order to tackle these conditions effectively.”
This article has been republished from materials provided by University of Sydney. Note: material may have been edited for length and content. For further information, please contact the cited source.
Jacqueline Stöckli, Kelsey H. Fisher-Wellman, Rima Chaudhuri, Xiao-Yi Zeng, Daniel J. Fazakerley, Christopher C. Meoli, Kristen C. Thomas, Nolan J. Hoffman, Salvatore P. Mangiafico, Chrysovalantou E. Xirouchaki, Chieh-Hsin Yang, Olga Ilkayeva, Kari Wong, Gregory J. Cooney, Sofianos Andrikopoulos, Deborah M. Muoio, David E. James. Metabolomic analysis of insulin resistance across different mouse strains and diets. Journal of Biological Chemistry, 2017; jbc.M117.818351 DOI: 10.1074/jbc.M117.818351.
Promise for Combating Harmful Algal BloomsNews
A cheap, safe and effective method of dealing with harmful algal blooms is on the verge of being introduced following successful field and lab tests. Moves to adopt use of hydrogen peroxide (H2O2) as an effective treatment against toxic algae are already underway following the results of new research.READ MORE
The Smoke Screen - Sensor Arms Race is OnNews
The military uses smoke grenades in dangerous situations to provide cover for people and tanks on the move. But increasingly, sensors can now go beyond the visible range into the infrared (IR) region of the spectrum. Today, researchers report developing a new kind of smoke that obscures both visible and IR detection.READ MORE
Grape Waste Goes From Landfill to LipstickNews
The world drinks a lot of wine, and that means a lot of grapes are consumed every year. But not every part of the grape ends up in the bottle. Seeds, stalks and skins are typically discarded in landfills as waste. But now, researchers say they have found some useful commercial applications, such as prolonging the shelf life of fatty foods, for these wine leftovers.READ MORE
Comments | 1 ADD COMMENT
Beverly Ogunleye | Nov 29, 2017
The only symptom that I had was tingling in my legs especially at night after I retired to bed. The tingling became more severe where I could not get them to stop. I thought I had restless leg syndrome. My doctor tested me for diabetes and found that I had type II diabetes and the sugar was attacking my legs because it had no place to go. He put me on a sugar free diet and Actos and within one to two days my symptom were gone.. One day I got extremely sick, could not keep anything down, had blurry vision, a rapid heartbeat.I Started taking metformin 1000 mg twice daily. I am writing this to inform others that nothing was really working to help my condition.I went off the metformin (with the doctor’s knowledge) and started on Diabetes herbal formula i ordered from Health Herbal Clinic, my symptoms totally declined over a 7 weeks use of the Diabetes natural herbal formula. i am now doing very well, Visit there website www. healthherbalclinic. net or email Info@ healthherbalclinic. net This treatment is incredible!
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018